KSB Ltd manufactures pumps and valves for energy, water, industry and nuclear projects, and its Q2 FY 2026-2027 print arrives with H1 margins (11.34% EBITDA margin) running well below the guided 13-14% level. The quarter will speak to whether the September commodity price spike compressed margins further and whether nuclear pump testing and the promised H2 export recovery are on track.
| Results date | November 03, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 6,907 Mn (Rs. 690.70 Cr), up 3.60% YoY |
| Previous quarter PAT | Rs. 596 Mn (standalone), down 18.02% YoY |
| Previous quarter EBITDA margin | 11.34% (H1 ended June 30, 2026) |
| Market cap | Rs. 11,520.48 Cr |
| CMP | Rs. 662.15 |
As per the board-meeting intimation, the Board will meet on November 3, 2026 to consider the results for the quarter ended September 30, 2026. The trading window was shut from October 1, 2026 ahead of the results.
The key question for KSB's Q2 FY 2026-2027 print is the margin bridge: H1 EBITDA margin stood at 11.34% against management's guided 13-14% level, and WPI inflation hit a series-high 11.39% in September 2026, with basic metals at 16.96% and fuel and power at 25.85% — a cost backdrop that works directly against margin recovery given management's admitted sub-100% pass-through of commodity costs. On the nuclear front, the ₹28,000 Cr Mahi Banswara NIMEP tender (bids due September 30, 2026) and RAPP-8 fuel loading on September 19, 2026 confirm the PHWR pipeline behind KSB's ₹1,235 Cr nuclear pump order book, but no confirmation was found that GHAVP main-coolant-pump testing resumed in September — the proof point management tied double-digit full-year top-line growth to, leaving the 2-4 pump invoicing commitment for this fiscal unverified entering the print. Solar remains back-loaded: PM-KUSUM 2.0 was still only 'launching soon' as of September 9, 2026, against H1 solar revenue of ₹50-60 Cr that was below expectations, though MSEDCL's state awards (₹235.92 Cr for 10,000 pumps to Shakti Pumps) show the tender tap opening. The export recovery management guided to for H2 2026 had not visibly begun at quarter-end, with the Middle East conflict escalating through the window and US tariffs of 10-12.5% on 60 trading partners still in force — the Dangote order ($12.4 Mn, September 4) is the one in-window export positive. Working capital is another watch area, with inventories at ₹961 Cr and trade receivables at ₹800.5 Cr as of June 30, 2026 against H1 operating cash flow of just ₹15.5 Cr, and management has promised an H2 improvement in receivable days and inventory drawdown.
Performance vs Guidance Tracking: Key guidance items management has previously committed to, and what to check on this call:
Nuclear execution and NPCIL test-bed dependency
Margin bridge and commodity pass-through
Order intake momentum and export recovery
Working capital: receivables and inventory
Standalone revenue rose 3.60% YoY to Rs. 690.70 Cr in the quarter ended June 30, 2026, but PAT fell 18.02% YoY to Rs. 596 Mn. Management attributed the H1 EBIT margin decline primarily to not achieving planned sales growth, which hit gross margins and operating expenses, alongside 'continued geopolitical uncertainties, margin pressures, and profitability impacts'.
Valve margins dropped to single digits in H1 2026 (4.07% segment margin in the June quarter) versus a historical 13-14% profitability profile, which management called a temporary combination of commodity prices, mix, exports and lower sales. Management expects a return to double digits, though no specific timeline was given.
KSB's nuclear pump order book stood at ₹1,235 Cr as of June 2026, including the Kudankulam order worth almost ₹280-290 Cr of which only ₹30-40 Cr had been delivered. Management has guided for 2-4 nuclear pump invoicings this fiscal year, contingent on the NPCIL test-bed issue being resolved, with the majority of the order book converting over 2026-2028.
H1 2026 solar revenue of ₹50-60 Cr was below expectations due to the KUSUM 2.0 delay, and solar pumps are currently 5-7% of the order book against a 10-12% target. PM-KUSUM 2.0 was still only 'launching soon' as of September 9, 2026, while MSEDCL began awarding state solar-pump packages in September.
Management has guided for a consistent EBITDA margin of 13-14% and explicitly does not aim for 15-16%, prioritising top-line growth instead. H1 2026 EBITDA margin was 11.34%, down 2.19 pp YoY, with margin recovery tied to top-line achievement and mix from aftermarket and nuclear orders.